Scientific Advisors

    The following individuals are contributing as scientific advisors to the successful commercialization of Bioxiness’ novel drugs:

    • Paul Luciw, PhD, UC Davis, Chairman, Scientific Advisory Board
    • Bruce Ames, PhD, UC Berkeley (expertise - antimicrobial discovery)
    • Michael Goodson, PhD, UC Davis (expertise – biochemistry, cell biology)
    • John Hershey, PhD, UC Davis (expertise – protein biosynthesis)
    • Hiroshi Nikaido, MD, UC Berkeley (drug transport "efflux pump", bacterial resistance)
    • Martin Robson, MD, University of South Florida (clinical development)
    • Albert T. Sheldon, PhD, Former FDA Microbiology Supervisor/Center for Drug Evaluation & Research (regulatory affairs)

     


    © 2017 Bioxiness Pharmaceuticals. All Rights Reserved.